ADMA Biologics (ADMA) director granted new RSUs and 17,730 stock options

Rhea-AI Filing Summary

ADMA Biologics director Alison C. Finger received new equity awards in the form of restricted stock units (RSUs) and stock options on February 9, 2026. She acquired 10,690 RSUs at a price of $0, bringing her directly held common stock and RSU-related holdings to 45,619 shares.

The 10,690 RSUs vest in two equal installments on the six- and 12‑month anniversaries of the grant date, becoming fully vested after one year, subject to continued service. She was also granted stock options for 17,730 shares of common stock at an exercise price of $16.37, which vest in twelve equal monthly installments over one year.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider FINGER ALISON CECILY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	17,730	$0.00	--
Grant/Award	Common Stock	10,690	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 17,730 shares (Direct); Common Stock — 45,619 shares (Direct)

Footnotes (1)

1. These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date. Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 29,484 shares of common stock owned by the Reporting Person. These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FINGER ALISON CECILY

(Last) (First) (Middle)

C/O ADMA BIOLOGICS, INC.

465 STATE ROUTE 17

(Street)

RAMSEY NJ 07446

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ADMA BIOLOGICS, INC. [ ADMA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		10,690(1)	A	$0	45,619(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$16.37	02/09/2026		A		17,730		(3)	02/09/2036	Common Stock	17,730	$0	17,730	D

Explanation of Responses:

1. These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.

2. Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 29,484 shares of common stock owned by the Reporting Person.

3. These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

	/s/ Alison C. Finger, by Michael A. Goldstein as Attorney-in-fact	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ADMA (ADMA) report for Alison C. Finger?

ADMA reported that director Alison C. Finger received new equity awards on February 9, 2026. She acquired 10,690 restricted stock units and stock options covering 17,730 shares as part of her director compensation, with both grants vesting over a one-year period.

How many ADMA (ADMA) RSUs were granted to Alison C. Finger and how do they vest?

Alison C. Finger received 10,690 ADMA restricted stock units on February 9, 2026. These RSUs vest in two equal installments on the six- and 12‑month anniversaries of the grant date, becoming fully vested after one year, assuming she continues serving the company.

What stock options were granted to ADMA (ADMA) director Alison C. Finger?

She was granted stock options for 17,730 shares of ADMA common stock at a $16.37 exercise price. These options vest in twelve equal monthly installments and become fully vested on the one‑year anniversary of the grant date, contingent on continued service.

What is Alison C. Finger’s ADMA (ADMA) beneficial ownership after this Form 4?

Following these grants, Alison C. Finger beneficially owns 45,619 ADMA shares in direct form. This figure includes common stock, previously granted restricted stock units, and the 10,690 new RSUs awarded on February 9, 2026, according to the filing’s footnote disclosure.

Are Alison C. Finger’s new ADMA (ADMA) RSUs subject to service conditions?

Yes, the RSUs are service-based awards. The 10,690 restricted stock units vest in two equal tranches at six and twelve months after grant, and vesting requires Alison C. Finger to remain in service with ADMA through each applicable vesting date.

Over what period do Alison C. Finger’s ADMA (ADMA) stock options vest?

The stock options granted to Alison C. Finger vest monthly over one year. They vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the February 9, 2026 grant date, provided she continues her service with the company.